LNWWM
INBX

Laird Norton Wetherby Wealth Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-131,023
Closed -$4.58M – 988
2024
Q1 		$4.58M Sell
131,023
-5,305
-4% -$193K 0.22% 78
2023
Q4 		$5.18M Hold
136,328
– – 0.27% 63
2023
Q3 		$2.5M Sell
136,328
-95
-0.1% -$1.99K 0.14% 139
2023
Q2 		$3.54M Hold
136,423
– – 0.19% 96
2023
Q1 		$2.57M Buy
136,423
+95
+0.1% +$2.21K 0.15% 137
2022
Q4 		$3.36M Sell
136,328
-1,000
-0.7% -$29.4K 0.22% 95
2022
Q3 		$2.46M Hold
137,328
– – 0.17% 110
2022
Q2 		$1.56M Buy
137,328
+105
+0.1% +$1.54K 0.11% 199
2022
Q1 		$3.06M Hold
137,223
– – 0.18% 103
2021
Q4 		$5.99M Hold
137,223
– – 0.34% 51
2021
Q3 		$4.57M Hold
137,223
– – 0.28% 61
2021
Q2 		$3.78M Buy
+137,223
New +$2.86M 0.23% 78

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's INBX Position: Q2 2024 in Review

Laird Norton Wetherby Wealth Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 131,023 shares — an estimated $4.58M sold.

Laird Norton Wetherby Wealth Management first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $5.99M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Laird Norton Wetherby Wealth Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 131,023 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $4.58M.
  • Laird Norton Wetherby Wealth Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Laird Norton Wetherby Wealth Management's Inhibrx, Inc. Common Stock position peaked at $5.99M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.